| Literature DB >> 34072454 |
Han-Sol Kang1,2, Hyung-Wook Kwon2, Di-Gud Kim2, Kwang-Rak Park2, Suk-Chan Hahm1, Jeong-Hyun Park2.
Abstract
This study aimed to investigate the effects of suboccipital muscle inhibition technique (SMIT) on active range of motion (AROM) of the ankle joint, lunge angle (LA), and balance in healthy adults, according to the duration of its application. A total of 80 participants were randomly allocated to the 4-min suboccipital muscle inhibition (SMI) group (SMI_4M, n = 20), 8-min SMI group (n = 20), 4-min sham-SMI (SSMI) group (n = 20), and 8-min SSMI group (n = 20). Accordingly, the SMIT and sham SMIT were applied for 4 min or 8 min in the respective groups. AROM of dorsiflexion and LA were assessed, and a single leg balance test (SLBT) was performed before and after the intervention. AROM (4 min, p < 0.001; 8 min, p < 0.001), LA (4 min, p < 0.001; 8 min, p < 0.001), and SLBT (4 min, p < 0.001; 8 min, p < 0.001) significantly improved after SMI application. Compared with the SSMI group, the SMI group showed a significant increase in AROM (p < 0.001), LA (p < 0.001), and SLBT (p < 0.001). Except for SLBT (p = 0.016), there were no significant interactions between intervention and application duration. The results suggest that the SMIT, at durations of both 4 and 8 min, could be effective tools for improving AROM, LA, and balance.Entities:
Keywords: ankle joint; balance; lunge angle; randomized controlled trial; range of motion test; suboccipital muscle inhibition technique
Year: 2021 PMID: 34072454 PMCID: PMC8227022 DOI: 10.3390/healthcare9060646
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1Interventions. (A). Suboccipital muscle inhibition technique, (B). Sham suboccipital muscle inhibition technique.
Figure 2Flow diagram of the participants.
General characteristics of participants by study group.
| Variables | SMI_4M | SSMI_4M | SMI_8M | SSMI_8M |
|
|
|---|---|---|---|---|---|---|
| Sex† | ||||||
| Male | 11 | 11 | 11 | 11 | 0.000 | 1.000 |
| Female | 9 | 9 | 9 | 9 | ||
| Age (year) | 37.7 ± 7.3 | 37.5 ± 6.4 | 37.5 ± 5.3 | 37.7 ± 5.3 | 0.007 | 0.999 |
| Height (cm) | 171.3 ± 8.8 | 171.6 ± 7.2 | 171.5 ± 9.2 | 171.3 ± 9.7 | 0.007 | 0.999 |
| Weight (kg) | 68.6 ± 13.8 | 67.7 ± 14.3 | 68.2 ± 15.1 | 68.1 ± 13.8 | 0.012 | 0.998 |
SMI_4M, suboccipital muscle inhibition for 4 min; SSMI_4M, sham suboccipital muscle inhibition for 4 min; SMI_8M, suboccipital muscle inhibition for 8 min; SSMI_8M, sham suboccipital muscle inhibition for 8 min. Values are expressed as mean ± SD or † number of participants.
Changes of AROM, LA, and balance in each group.
| Variables | Pre | Post |
|
|
|
|---|---|---|---|---|---|
| AROM (°) | |||||
| SMI_4M ( | 23.0 ± 5.1 | 29.5 ± 5.6 | −14.875 | <0.001 * | 3.326 |
| SSMI_4M ( | 25.3 ± 4.9 | 25.6 ± 4.9 | −1.312 | 0.205 | 0.293 |
| SMI_8M ( | 25.0 ± 4.1 | 30.6 ± 5.2 | −9.752 | <0.001 * | 2.181 |
| SSMI_8M ( | 25.0 ± 5.8 | 25.2 ± 5.8 | −1.291 | 0.212 | 0.289 |
| LA (°) | |||||
| SMI_4M ( | 46.1 ± 6.9 | 51.2 ± 6.7 | −12.177 | <0.001 * | 2.723 |
| SSMI_4M ( | 47.4 ± 5.6 | 47.2 ± 5.9 | 1.080 | 0.294 | 0.241. |
| SMI_8M ( | 48.4 ± 5.2 | 52.6 ± 5.8 | −12.575 | <0.001 * | 2.812 |
| SSMI_8M ( | 48.4 ± 5.2 | 52.6 ± 5.8 | −0.839 | 0.412 | 0.188 |
| Balance (sec) | |||||
| SMI_4M ( | 81.7 ± 31.1 | 109.9 ± 42.6 | −4.647 | <0.001 * | 1.039 |
| SSMI_4M ( | 80.1 ± 45.4 | 86.3 ± 44.5 | −1.841 | 0.081 | 0.412 |
| SMI_8M ( | 72.7 ± 33.4 | 119.5 ± 45.3 | −6.761 | <0.001 * | 1.512 |
| SSMI_8M ( | 91.8 ± 34.5 | 91.6 ± 35.2 | 0.080 | 0.937 | 0.018 |
AROM, active dorsiflexion range of motion; LA, lunge angle; SMI_4M, suboccipital muscle inhibition for 4 min; SSMI_4M, sham suboccipital muscle inhibition for 4 min; SMI_8M, suboccipital muscle inhibition for 8 min; SSMI_8M, sham suboccipital muscle inhibition for 8 min; d: Effect size caculated with Cohen’s d. Values are expressed as mean ± SD. * p < 0.05.
Comparisons in AROM, LA, and SLBT for the intervention and application duration.
| Variables | SMI_4M | SSMI_4M | SMI_8M | SSMI_8M |
|
| Partial |
| |
|---|---|---|---|---|---|---|---|---|---|
| AROM (°) | 6.5 ± 1.9 | 0.2 ± 0.7 | 5.6 ± 2.6 | 0.2 ± 0.8 | I | 237.613 | <0.001 * | 0.758 | 0.762 |
| T | 1.421 | 0.237 | 0.018 | ||||||
| I×T | 1.358 | 0.248 | 0.018 | ||||||
| LA (°) | 5.1 ± 1.9 | −0.2 ± 0.8 | 4.3 ± 1.5 | 0.1 ± 0.7 | I | 261.920 | <0.001 * | 0.775 | 0.778 |
| T | 0.829 | 0.365 | 0.011 | ||||||
| I×T | 3.637 | 0.060 | 0.046 | ||||||
| Balance (sec) | 28.1 ± 27.1 | 6.2 ± 15.1 | 46.8 ± 30.9 | −0.2 ± 12.6 | I | 45.764 | <0.001 * | 0.376 | 0.412 |
| T | 1.440 | 0.234 | 0.019 | ||||||
| I×T | 6.057 | 0.016 * | 0.074 |
AROM, active dorsiflexion range of motion; LA, lunge angle; SMI_4M, suboccipital muscle inhibition for 4 min; SSMI_4M, sham suboccipital muscle inhibition for 4 min; SMI_8M, suboccipital muscle inhibition for 8 min; SSMI_8M, sham suboccipital muscle inhibition for 8 min; I, intervention (SMI vs. SSMI); T, application duration (4 min vs. 8 min); T×I, application time and duration interaction; η2, eta squared; R2, coefficient of variation. Values are expressed as mean ± SD in post values–pre values. * p < 0.05.